|
Symbol
|
RMALXV | RMAQ1V | NUHRCH | RMADXV | RMAG6V | HZWEFG | KYCYDU | KYCUDU | RMAZKV | RMAUGV | OJSRCH | RMA23V | KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | RMA7AV | AAHKTQ | OMFRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible |
|
Sous-jacent
|
Nestlé S.A. / Novartis Sandoz Basket / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N / UBS Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | Novartis AG / Roche PS / Swiss Life Hldg. N / UBS Group AG | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG / UBS Group AG / Zurich Insurance Group AG | Julius Baer Group / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swissquote Group Hldg. S.A. / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Novartis AG / Straumann Hldg. AG / UBS Group AG | Nestlé S.A. / Roche PS / UBS Group AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
22.06.2026 | 10.08.2026 | 26.08.2026 | 19.04.2027 | 24.11.2026 | 22.05.2026 | 05.06.2026 | 05.06.2026 | 08.06.2026 | 26.05.2026 | 14.06.2027 | 21.12.2026 | 29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 06.07.2026 | 08.07.2026 | 08.07.2026 |
| Demande | 99,21 | 99,01 | 98,49 | 98,11 | 100,40 | 100,01 | 93,55 | 93,70 | 99,11 | 96,42 | 95,35 | 96,82 | 92,20 | 92,10 | 96,71 | 93,65 | 92,05 | 95,52 | 99,42 | 99,58 |
| Offre | 100,81 | 101,01 | - | 99,70 | 100,30 | - | 94,55 | 94,70 | 100,71 | - | 96,15 | 98,40 | 93,20 | 93,10 | - | 94,65 | 93,05 | 97,09 | - | - |